Cogent Biosciences · 3 hours ago
Associate Director, Commercial Congress Strategy and Execution
Waltham, Massachusetts, United States
Full-time
Onsite
Lead/Staff, Director/Executive
$175K/yr - $200K/yr
5+ years expCogent Biosciences is a biotechnology company focused on developing precision therapies for patients with unmet medical needs. The Associate Director of Commercial Congress Strategy and Execution will lead the strategic planning and execution of scientific congresses to support the launch of their key pipeline asset, bezuclastinib, while ensuring cohesive collaboration across teams and optimizing customer engagement at these events.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop and implement a centralized congress strategy aligned with brand and franchise imperatives
Lead annual congress planning cycles, including sponsorship decisions, booth presence, key onsite events, and omnichannel integration
Partner with Medical Affairs, Marketing, Sales, and Compliance to ensure cohesive and compliant congress execution
Collaborate cross-functionally to ensure commercial meeting objectives are accomplished
Oversee Tier 1 congresses across priority therapeutic areas, ensuring high-quality delivery of all touchpoints
Serve as Project Owner for congress assets (e.g., booth schematics, pre-conference decks) and manage internal review processes (e.g., MLR and other approval processes as required)
Manage external vendors and agencies to deliver congress experiences on time and within budget
Oversee planning and coordination with external partners for flawless meeting execution throughout all phases of development
Facilitate alignment across medical strategy, field teams, communications, and sponsorships
Lead workstreams to assess and evolve congress capabilities, vendor partnerships, and ways of working
Build and lead key initiatives to ensure key stakeholder objectives are accomplished upon completion
Own congress budget forecasting, PO management, accruals, and financial reporting
Develop and implement congress performance measurement frameworks and share insights to optimize future investments
Ability to negotiate with external vendor partners to ensure fiscal responsibility
Qualification
Required
Bachelor's degree required
5-8 years of experience in pharmaceutical marketing, medical communications, or congress planning
Proven track record of leading congress strategy and execution in a highly regulated industry
Experience with Veeva Vault or similar promotional review systems
Involvement with large-scale, highly complex internal meetings
Strong strategic thinking and project management capabilities
Excellent interpersonal, written, and verbal communication skills
Ability to influence cross-functional teams without direct authority
Financial acumen and experience managing large budgets
Comfortable navigating ambiguity and managing multiple priorities in a fast-paced environment
Up to 30% travel required, including international congresses and weekend events
Benefits
100% of medical, dental, and vision premiums for you and your family
Up to 75% of in-network deductibles
401(k) match with immediate vesting
Generous paid time off
12 weeks of fully paid parental leave
Paid family and medical leave for all employees regardless of location
Company-paid short-term disability coverage for up to 20 weeks
Wellness programs
Tuition reimbursement
Inclusive family-forming support
Company
Cogent Biosciences
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
51-200 employees
H1B Sponsorship
Cogent Biosciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (3)
Funding
Current Stage
Public CompanyTotal Funding
$1.6BKey Investors
Commodore CapitalFairmount Funds ManagementSquare 1 Bank
2025-11-10Post Ipo Equity· $200M
2025-11-10Post Ipo Debt· $200M
2025-07-08Post Ipo Equity· $230M
Leadership Team
Andrew Robbins
CEO and President
A
Abb Hayden
Senior Vice President of Sales
Recent News
2025-12-31
Company data provided by crunchbase